From FY2022 onwards, the Clinical & Systems Innovation Category consists of the Clinical Systems Innovation (CSI) - Main Grant and Innovation Seed Grant (ISG).

The Clinical & Systems Innovation - Main Grant aims to promote clinical and systems innovations to transform healthcare, in support of SingHealth Duke-NUS AMC priorities.

The programmes should demonstrate potential scaling, prospective proof-of-value, and impact to be delivered within ours and other healthcare system. The proposals should be positioned to apply for external late-stage translational grants such as AM MedTech grant, NRF Central Gap, NHIC I2D / I2I or take other concrete steps to develop the technology towards adoption and/or commercialisation at the end of the project.

Awards will be based on alignment with the Clinical & Systems Innovation (CSI) funding support priorities & objectives, feasibility of implementation and scaling, degree of innovativeness, potential impact, and the promotion of collaboration between inter-professional groups.

The Innovation Seed Grant aims to promote clinical and systems innovation to transform healthcare and in an effort to kick-start early stage innovation projects. It is a funding support introduced to kickstart ideation, by translating ideas into working prototypes to gather feedback from potential users as well as to test the technical feasibility of the proposed solution for potential scalability across the cluster in support of the SingHealth Duke-NUS AMC and AMII priorities.

Awards will be based on alignment with the Innovation Seed Grant priorities & objectives, magnitude of the clinical need or gap, potential for adoption and scaling, degree of innovativeness and potential impact.

For both CSI - Main Grant and ISG, proposals that demonstrate potential for cross-campus collaboration, highlighting interdisciplinary partnerships and resource-sharing across the different campuses are encouraged. Proposals that include cross-campus collaboration will be prioritised for funding during the evaluation process.

It is recommended that the PI notify SingHealth Office of Intellectual Property (SHIP) at ship@singhealth.com.sg to ensure that valuable proprietary information is not disclosed.

General Information

Important dates to note	Details
6 August 2025	Start of grant call Submit your application through the AMgrants System. For any enquiries regarding the different support domains, please contact: Education (EDU) Support - Lin Fenru (lin.fenru@duke-nus.edu.sg) Clinical & Systems Innovation (CSI) Support - Main Grant - Jobeth Lim Kar Yee (jobethlim@duke-nus.edu.sg) Clinical & Systems Innovation (CSI) Support - Innovation Seed Grant (ISG) - Ranjan Sekeran (ranjan.sekeran@partner.nus.edu.sg) Research Support, including Pitch-for-Fund (PFF) and Nurturing Clinician Researcher Scheme (NCRS) - Lin Qiaojun (lin.qiao.jun@duke-nus.edu.sg) Global Health (GH) Support - Yeng Ai Foong (aifoong@duke-nus.edu.sg)
30 September 2025	Close of grant call.
November, December 2025 and January 2026	Pitch/Interview Sessions
February/March 2026	Announcement of Grant Results.

For enquiries on ACP Programme Grants, please contact Joint Office of Academic Medicine - Academic Programmes Management Department (JOAM-APMD): academic-medicine@duke-nus.edu.sg

For assistance and clarifications on grant application form, please contact SingHealth Office for Innovation (SHOFI): innovate@singhealth.com.sg

For applicants who are not affiliated to an ACP, and/or would like assistance to be linked up with potential ACP collaborators, please contact SingHealth Office for Innovation (SHOFI): innovate@singhealth.com.sg

CSI Main

Download Guides and Forms

i. The duration of funding support may range for a year and up to a maximum of 3 years, at the point of application.

ii. Each proposal is capped at S$100,000.

Please refer to AM Funding Guidelines for more information on fundable and non-fundable items.

Please take note of the following in the budget request:

Overseas travel expenses (e.g. overseas conference, seminars, etc.) are not supportable.

iii. Project Team may want to consider including budget for the relevant services in their proposals:

For related project support, technical support or advisory, please contact Medical Technology Office (MTO) at mto@singhealth.com.sg
For the evaluation of the impact of the healthcare innovation, i.e., how the innovation will improve the health system, in terms of resource and cost savings and improved health and patient care outcomes, project team may consider including a budget of ~10% of grant quantum in their budget request. The Impact Assessment Unit (IAU) is a resource under the AMII which you may tap on for guidance and expertise on such evaluation (e.g. cost-utility and cost effectiveness analyses). Please contact Ms Elaine Tai (elaine.tai@singhealth.com.sg ) for further queries.

i. Clinicians with Duke-NUS Faculty or Non-Faculty Academic Appointment are eligible to apply. A Co-PI is required if an applicant does not have a Duke-NUS Academic Appointment.

ii. Nurses, Allied Health Professionals (AHPs), administrators and doctors are encouraged to participate in collaboration with ACPs.

iii. Clinical research and education research projects are not supported by the CSI grant. Please seek alternative funding support from the institution or research / education offices. Education projects could be supported under ACP Programme Grants – Education Support.

Each proposal should demonstrate alignment with goals of academic medicine and Academic Medicine Innovation institute (AMII) priorities, with focus on its impact to the SingHealth Duke-NUS AMC, the ACP and locally within Singapore. All project activities are to be conducted locally and within Singapore.

All applications must be submitted through AMgrants System.

Please click here for the information sheet for CSI Main Grant.
Please click here for the template on Collaboration & Procurement Framework for Innovation Projects for CSI Main Grant.

Innovation Seed Grant

Download Guides and Forms

i. The duration of funding support may be up to a maximum period of 18 months (inclusive of any extension).

ii. Each proposal is capped at S$25,000.

Please refer to AM Funding Guidelines for more information on fundable and non-fundable items.

Please take note of the following in the budget request:

Overseas travel expenses (e.g. overseas conference, seminars, etc.) are not supportable.
Budget items should focus on development of prototype and getting the initial project up and functioning. These will take precedence over the cost of publication, patent filing etc. at the early stage.

i. Clinicians with Duke-NUS Faculty or Non-Faculty Academic Appointment are eligible to apply. A Co-PI is required if an applicant does not have a Duke-NUS Academic Appointment.

ii. Nurses, Allied Health Professionals (AHPs), administrators and doctors are encouraged to participate in collaboration with ACPs.

iii. Applicants should not have received any similar seed stage type funds from institutions or domains. Applicants who are eligible for such grants from their respective institutions may be directed to those opportunities.

iv. Clinical research and education research projects are not supported by the CSI grant. Please seek alternative funding support from the institution or research / education offices. Education projects could be supported under ACP Programme Grants – Education Support.

All applications must be submitted through AMgrants System.

Application must include the following: